Detailed
Conference Schedule
AR-BIC
Second Annual Conference - April 17-18, 2016
|
DAY
1 - Welcome Reception & Poster Session
Wednesday,
Apil 17: Arkansas Research Alliance Reception and Poster Session
5:00 to 9:00 PM
at the
Embassy Suites, Little Rock, AR , Little Rock, Arkansas - Ambassador I -
III Rooms |
- 5:00 PM - 9:00PM - Registration
- 5:30 PM - 9:00PM - Poster Session
- 6:00 PM - 9:00PM - Evening Reception (Sponsored by Arkansas Research
Alliance)
|
DAY
2 - Opening, Presentations & Posters Continue
Monday,
April 18: AR-BIC Conference 8:00 AM to 5:30 PM
at the
Embassy Suites, Little Rock, AR , Little Rock, Arkansas |
8:30
- 9:00 Light Breakfast |
9:00
- 9:30 Wecome Remarks and Opening |
- Jerry
Adams, President and CEO, Arkansas Research Alliance, Conway,
AR
- William Slikker,
Jr., Ph.D., Director, National Center for Toxicological
Research, US Food and Drug Administration, Jefferson,
AR
- Daniel
Rahn,
M.D., Chancellor, University of Arkansas for Medical Sciences, Little
Rock, AR
|
9:30 – 12:15
AM
Session
1: Bioinformatics based technologies for precision medicine
Session
Chair: Weida Tong, Ph.D., Director, Division of Bioinformatics and Biostatistics,
National Center for Toxicological Research, Jefferson, Arkansas |
- 9:30 -
10:15 AM
- Precision
Medicine: Challenges and Limitations
Christos Hatzis, Ph.D.,
Assistant Professor of Medicine, Director of Bioinformatics,
Breast Medical Oncology,
Yale Comprehensive Cancer Center, New Haven,
CT
- 10:15
- 10:45
- 10:45 - 11:30
- Imaging Informatics: Adding Dimensions to Co-Clinical
Trials
Fred
Prior, Ph.D., Inaugural
chair of the Department of Biomedical Informatics,
University of Arkansas for Medical Sciences, Little
Rock, AR
- 11:30 - 12:15
- Establishing the New Molecular Bioinformatics Core
(mBIO)
Daniel
Johnson, Ph.D., Director of Molecular
Bioinformatics, University of Tennessee Health
Science Center (UTHSC), Memphis, TN
|
12:15
- 1:00 PM Lunch Break |
1:00– 2:45
PM
Session
2: Non-Invasive Liquid Biopsy for Cancer Diagnosis and Prognosis:
FDA BAA Project overview & biological background
Session Chair : Donald Johann, MS, MD, FACP, Associate Professor of
Medicine and Bioinformatics, Scientific Director of the UAMS Genomics
Sequencing Facility, Little Rock, AR |
- 1:00 - 1:45
- Scientific and methodological advancements in liquid biopsies
to further the development of lung cancer-based precision medicine
Donald Johann, MS, MD, FACP, Associate Professor of Medicine and
Bioinformatics, Scientific Director of the UAMS Genomics Sequencing
Facility, Little Rock, AR
- 1:45 - 2:15
- Lung Cancer and the new Rx landscape
Konstantinos Arnaoutakis, M.D., Associate Professor, Department
of Internal Medicine, Hematologist, Winthrop P. Rockefeller
Cancer Institute, UAMS, Little Rock, AR
- 1:45 - 2:15
- ccfDNA: the basics, challenges and potential clinical applications
Wenming Xiao, Ph.D., Staff Scientist, Division of Bioinformatics
and Biostatistics, National Center for Toxicological Research,
US Food
and Drug Administration, Jefferson, AR
|
3:00 – 4:45
PM
Session
3: Pipeline & computational approaches
Session Chair : Donald Johann, MS, MD,
FACP, Associate Professor of Medicine and Bioinformatics, Scientific
Director of the UAMS Genomics Sequencing Facility, Little Rock, AR |
- 3:00 - 3:30
- DNA-based computational approaches
Xiuzhen Huang, Ph.D., Professor of Computer Science, Arkansas State
University, Jonesboro, AR
- 3:30 - 4:00
- RNA-based computational approaches
Mary Yang, Ph.D., Associate Professor, University of Arkansas
at Little Rock, Little Rock, AR
- 4:00 - 4:30
- DNA
methylation analysis & computational approaches
Karl Walker, Ph.D., Assistant Professor, University of Arkansas
at Pine Bluff, Pine Bluff, AR
|
4:30– 4:45
PM Closing Remarks
• Weida Tong, Ph.D., Director, Division of Bioinformatics
and Biostatistics, National Center for Toxicological Research, Jefferson,
AR
• Jerry B. Adams, President and CEO, Arkansas Research Alliance, Conway,
AR
|
|
|